Ab&B Bio-Tech has joined the stacked roster of drug developers queuing up to go public in Hong Kong, filing the paperwork for ...

While drugmakers are hard at work on the shots, they’re not yet ready to blunt the impact of a potential pandemic.

The latest funding is a sign of how seriously the Biden administration appears to be taking the pandemic threat.

The new agreement comes at a time when GSK and CureVac have been at risk of falling behind in mRNA vaccines for respiratory diseases, with combined flu/COVID-19 candidates from Moderna and Pfizer ...

GSK said at an R&D update in the summer that it expects to have two mRNA candidates in clinical trials within 12 months and six within the next four years, including seasonal flu shots.

The European Commission has just approved the prepandemic vaccine Prepandrix from GlaxoSmithKline ... application for its own prepandemic flu vaccine, Aflunov. The European Medicines Agency's ...

Moderna, Pfizer, and a partnership between GSK and CureVac are reportedly working ... and Prevention reported the first death from bird flu on Monday, announcing an elderly patient with underlying ...

Moderna has been testing an mRNA candidate for influenza viruses like the H5 and H7 strains that are seen as pandemic threats ...

Trump Administration Halts All Communications From The Centers For Disease Control As Bird Flu Spreads As the bird flu virus continues to spread through the United States, the Trump administration ...